Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts

Lallemand F., Schmitt M., Bourges J.-L., Gurny R., Benita S., Garrigue J.-S.

2017
European Journal of Pharmaceutics and Biopharmaceutics

View publication

Therapeutic Area

Front of the eye (FOTE)
Technology

Drug Delivery

Affiliations

Santen SAS, Evry, France; Department of Ophthalmology, Paris Descartes School of Medicine, Assistance Publique-Hôpitaux de Paris, Cochin-Hôtel-Dieu Hospital, Université Sorbonne Paris Cité, Paris, France; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, Israel

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.

Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022